GLP-1 agonists include (not all are available in Australia): semaglutide (brand names Ozempic, Wegovy, Rybelsus), liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), exenatide (Byetta, Bydureon) and lixisenatide (Lyxumia, Adlyxin)
Build Habits That Stick The key to lasting change
Metabolic syndrome with elevated liver enzymes : Patients presenting with multiple metabolic risk factors (central obesity, hypertension, dyslipidemia, impaired fasting glucose) and persistently elevated ALT/AST may benefit from the comprehensive metabolic improvements offered by GLP-1 therapy
That averages out to a 5% weight loss without even utilizing the maximally tolerated dose
76 WangC.KavalaliE.MonteggiaL
Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes